Skip to content

Comparative Evaluation of CTG With and Without rhPDGF- BB Using Modified Coronally Advanced Tunnel for Root Coverage

Comparative Evaluation of rhPDGF- BB With Modified Coronally Advanced Tunnel and CTG Versus Modified Coronally Advanced Tunnel With CTG Alone for Root Coverage in Multiple Mandibular Gingival Recession Defects- A RCT

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03676088
Enrollment
6
Registered
2018-09-18
Start date
2016-11-30
Completion date
2018-07-31
Last updated
2018-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gingival Recession

Brief summary

The present study is a human, prospective, single centre, single blind, comparative controlled randomized clinical trial for the treatment of Miller's Class I, II or combination of class I and II mandibular recession and comparing the clinical outcomes prior to and 6 months after treatment. The trial is in accordance to the Consolidated Standards of Reporting Trials (CONSORT) criteria, 2010.

Detailed description

24 recession defects were selected in patients who were systemically and periodontally healthy, satisfying the determined inclusion criteria. Patients with at least two or more teeth having Miller's class I , II or combination of class I and II mandibular recession defects were included in the study. A detailed, thorough medical and dental history was obtained and each patient was subjected to comprehensive clinical and radiological examination. All patients were informed about the nature of the study, surgical procedure involved, potential benefits and risks associated with the surgical procedure and a written informed consent was obtained from all patients. The patients were assigned into two treatment groups (test and control). The test group was treated with recombinant human Platelet Derived Growth Factor-BB and Modified Coronally Advanced Tunnel +Connective Tissue Graft whereas the control group was treated by Modified Coronally Advanced Tunnel +Connective Tissue Graft alone.

Interventions

PROCEDUREroot coverage

recession coverage is treated with modified coronally advanced tunnel with connective tissue graft with recombinant human platelet derived growth factor- BB for Experimental: Test group and without recombinant human platelet derived growth factor- BB for Active Comparator: Control group

Sponsors

Krishnadevaraya College of Dental Sciences & Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Computer generated randomization sequence was obtained by the assistant. Allocation concealment was achieved using a sealed coded opaque envelope containing the treatment of the specific subject The sealed envelope containing treatment assignment was opened immediately prior to surgery to prevent surgeon bias

Intervention model description

The patients were assigned into two treatment groups (test and control). The test group was treated with recombinant human Platelet Derived Growth Factor-BB and Modified Coronally Advanced Tunnel +Connective Tissue Graft whereas the control group was treated by Modified Coronally Advanced Tunnel +Connective Tissue Graft alone.

Eligibility

Sex/Gender
ALL
Age
21 Years to 58 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients fulfilling the following criteria were included in the study:- * Two or more teeth with Miller's class I and II or combined class I and II recession defects in mandibular anteriors. * Age group 21-58 years. * Patients with healthy or treated periodontal conditions. * Patients willing to participate in the study. * Absence of uncontrolled medical conditions. * Patients with full mouth plaque score \</= 10%(O'Leary 1972) * Patients with esthetic concerns. * Patients with thick gingival biotype \>0.8mm

Exclusion criteria

* Pregnant or lactating females. * Tobacco smoking. * Uncontrolled medical conditions. * Untreated periodontal conditions. * Use of systemic antibiotics in the past 3 months. * Patients treated with any medication known to cause gingival hyperplasia. * Drug and alcohol abuse * No occlusal interferences. * Patient with a known hypersensitivity to rhPDGF-BB.

Design outcomes

Primary

MeasureTime frameDescription
coverage esthetic score(RCES)6 monthsThe Aesthetic evaluation was performed according to the root coverage aesthetic score system (RES) Five Variables evaluated which are as follows: 1. Level of Gingival margin (GM) 2. Marginal Tissue Contour (MTC) 3. Soft Tissue Texture (STT) 4. Mucogingival Junction(MJ) alignment 5. Gingival Colour (GC)
2. Gingival Recession Width (GRW)6 monthsmeasured as the distance between the mesial gingival margin and distal gingival margin
Mean root coverage(MRC)6 months(Baseline recession depth - 6 month recession depth/Baseline recession depth)\*100
Complete root coverage(CRC)6 monthsroot coverage regarded as complete with gingival margin located at the level of Cemento Enamel Junction
Gingival recession depth (GRD)6 monthsmeasured as the distance from the Cemento Enamel Junction to the gingival margin

Secondary

MeasureTime frameDescription
clinical attachment level (CAL)6 monthsmeasured as Gingival Recession Depth + Probing Depth
width of keratinized tissue (KTW)6 monthsmeasured as the distance from the mucogingival junction to the gingival margin , with the mucogingival junction location determined using a visual method (Schiller's Potassium Iodide Solution).
probing pocket depth (PD)6 monthsmeasured as the distance from the gingival margin to the base of gingival sulcus

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026